Work

The role of HER-2 + Topo IIα amplification in predicting benefit from CAF dose escalation-CALGB 8541

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.9505

Authors: L. Harris, L. Dressler, D. Cowan, D. Berry, C. Cirrincione, G. Broadwater, H. Muss, D. Hayes, M. Ellis

Institutions: University of North Carolina at Chapel Hill, Duke University, Dana-Farber Cancer Institute, Duke Medical Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2209256294

Cites:

Cited by: 3

Related to: 10